Kathrin Jansen
Kathrin Jansen (pronounced: Kath-rin Yan-sen) is a prominent figure in the field of vaccine research and development. She is currently the Senior Vice President and Head of Vaccine Research and Development at Pfizer.
Etymology
The name Kathrin is of German origin and is a variant of Katherine, which means 'pure'. Jansen is a common Dutch and German surname, meaning 'son of Jan'.
Career
Kathrin Jansen has had a distinguished career in the field of biomedical research, with a particular focus on vaccine development. She has held leadership positions at several major pharmaceutical companies, including Merck and Wyeth, before joining Pfizer in 2010.
At Pfizer, Jansen has been instrumental in the development of several important vaccines, including the pneumococcal conjugate vaccine Prevnar 13 and the COVID-19 vaccine BNT162b2, developed in partnership with BioNTech.
Related Terms
External links
- Medical encyclopedia article on Kathrin Jansen
- Wikipedia's article - Kathrin Jansen
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski